← Back to Search

Composite Resin

SHOFU Beautifil II LS for Noncarious Cervical Lesions

N/A
Waitlist Available
Led By Gerard Kugel, DMD, MS, PhD
Research Sponsored by Tufts University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 18 months
Awards & highlights

Study Summary

This trial will compare the clinical effectiveness of a new composite resin (SHOFU Beautifil II LS) vs a control (3M/ESPE Filtek Supreme) for restoring non carious cervical lesions (class V lesions).

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hickel Criteria

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SHOFU Beautifil II LSExperimental Treatment1 Intervention
Composite: SHOFU Beautifil II LS, Bonding Agent: SHOFU BeautiBond
Group II: 3M/ESPE Filtek SupremeActive Control1 Intervention
Composite: 3M/ESPE Filtek Supreme, Bonding Agent: 3M/ESPE Scotchbond Universal
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SHOFU Beautifil II LS
2017
N/A
~50

Find a Location

Who is running the clinical trial?

Tufts UniversityLead Sponsor
261 Previous Clinical Trials
661,273 Total Patients Enrolled
Shofu Inc.Industry Sponsor
2 Previous Clinical Trials
74 Total Patients Enrolled
Gerard Kugel, DMD, MS, PhDPrincipal InvestigatorTufts University School of Dental Medicine
2 Previous Clinical Trials
308 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Apr 2025